ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 18300 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 18300; 2) Community: the network communities that were significantly associated with the response to NSC 18300; 3) Molecule: the relationships between components within communities and NSC 18300; 4) MDR: the compounds that were significantly associated with the NSC 18300.

NSC Compound Enrichment Correlation
NSC 720296 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1"-(4"-methyl)cyclohexane 0.0130238833303634 0.28435766
NSC 720727 Null 0.0130238833303634 0.094842429
NSC 729176 6,7-dimethyl-2-(thien-2-ylcarbonyl)-3-trifluoromethylquinoxa line 1,4-dioxide 0.0130238833303634 0.087236028
NSC 736104 Null 0.0130238833303634 -0.049891303
NSC 748705 Null 0.0130238833303634 0.31236506
NSC 752703 Null 0.0130238833303634 0.11108047
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0130238833303634 0.16821234
NSC 757925 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide 0.0130238833303634 0.24556841
NSC 758706 Simvastatin (USAN) 0.0130238833303634 0.11224993
NSC 7811 Ammonium, [4-[[p-(dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-ylidene]dimethyl-, chloride (8CI) 0.0130238833303634 0.096738209
Total:82  Current:27    [First] [Prev] [Next] [Last]